COLLETTE BROWN: Open Payments
NPI 1932203239 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 14 payments from 7 companies in 2025. Trend: 2023 $1,455 · 2024 $531 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $395 |
| Solventum Corporation | 2 | $168 |
| Genentech USA, Inc. | 1 | $150 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| UCB, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| Medtronic, Inc. | 3 | $62 |
Products named: Wegovy, PREVENA, Xolair, UPTRAVI, Nayzilam, ENTYVIO, MINIMED 780G, Ozempic.
Industry payments across NY — which companies pay providers there.
